Artificial Intelligence for Breast Cancer Screening
http://www.mammoscreen.com/Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 12, 2022 | Therapixel raises €15 million to boost AI-driven mammography reading | The French company specialising in design and commercialisation of AI-powered medical imaging software, Therapixel has raised €15 million in Series B funding. The new capital will boost its commercial presence in the U.S. The funding will a... |
| Jan 12, 2021 | Therapixel receives the CE mark for its Artificial Intelligence-based software (AI) MammoScreen™ USA - English France - Français España - español Deutschland - Deutsch | |
| Therapixel raises €15 million to boost AI-driven mammography reading | The French company specialising in design and commercialisation of AI-powered medical imaging software, Therapixel has raised €15 million in Series B funding. The new capital will boost its commercial presence in the U.S. The funding will a... |
Reviews 0
FAQ about Artificial Intelligence for Breast Cancer Screening
What has the press written about Artificial Intelligence for Breast Cancer Screening?
Parsers VC has collected 4 articles mentioning Artificial Intelligence for Breast Cancer Screening, among them “Therapixel raises €15 million to boost AI-driven mammography reading” (May 12, 2022) and “Therapixel receives the CE mark for its Artificial Intelligence-based software (AI) MammoScreen™ USA - English France - Français España - español Deutschland...” (Jan 12, 2021).
Is Artificial Intelligence for Breast Cancer Screening still active?
Yes, Artificial Intelligence for Breast Cancer Screening is active; its latest activity on Parsers VC dates from Oct 25, 2022.